Skip to content
Galderma logo — Advancing dermatology for every skin story

Galderma

Advancing dermatology for every skin story

Founded 1981 Switzerland Zug, Switzerland 8994 employees Post IPO Total: $22.95B

General Information

Company Name Galderma
Founded Year 1981
Location Switzerland Zug, Switzerland
Employees 8994
Funding Stage Post IPO
Business Model B2B2C, B2B, B2C
Revenue Model Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Galderma. To contact Galderma, visit galderma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Galderma compare?

A PDF of Galderma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Galderma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Galderma

Galderma, founded in 1981 and headquartered in Switzerland, positions itself as a leader solely dedicated to dermatology, aligning with its slogan, “Advancing dermatology for every skin story.” This strategic focus has enabled the company to construct a robust, innovative, science-based portfolio that spans Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.

Leveraging trusted partnerships with healthcare professionals, Galderma aims to meet the diverse needs of both consumers and patients, providing superior dermatological outcomes. This consumer-centric approach underscores the company's leadership in the skin health industry.

The company's financial credibility is reinforced by its recent Fr.4.90B secondary market investment on 01 March 2026, led by EQT Group. This significant investment signals strong confidence from the investor community and emphasizes Galderma's strategic potential for growth and innovation in dermatology.

Business keywords: Dermatology, Skin Health, Injectable Aesthetics, Dermatological Skincare, Therapeutic Dermatology, Consumer Care, Prescription Dermatology, Science-Based Portfolio, Innovative Skincare, Healthcare Partnerships, Patient Needs, Superior Outcomes, Sophisticated Brands, Healthcare Professionals

Services & Products

Injectable Aesthetic Solutions
Dermatological Skincare Products
Clinical Dermatology Solutions
Innovative Dermatology Research
Educational and Support Activities

Target Customers

Patients with Unique Skin Needs Healthcare Professionals in Dermatology Consumers Seeking Premium Skincare Doctors in Therapeutic Dermatology Individuals Seeking Dermatological Innovations

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Secondary Market Fr.4.90B 1
EQT Group
01 Mar 2026
Post-IPO Debt $175.00M 1
L'Oréal
01 Dec 2025
Secondary Market Fr.2.09B -
01 Jul 2025
Post-IPO Debt Fr.435.00M 5
The Group Ventures, UBS +3
01 Mar 2025
Post-IPO Debt $500.00M 1
L'Oréal
01 Aug 2024
IPO $3.65B -
01 Apr 2024
Growth Equity Non VC $1.00B -
01 Jun 2023
Acquisition Fr.10.20B 1
EQT Group
01 Oct 2019
Acquisition Undisclosed 1
Nestlé Health Science
01 Nov 2014

Galderma Alternatives & Competitors

Galderma vs

Experience unparalleled skin care excellence in Washington DC, with personalized treatments for all...

1 employees
Health Care, Wellness Beauty
Galderma vs

World Class Dermatology for Your Whole Family

48 employees
Biotechnology, Health Care
Galderma vs

We Deliver Extraordinary Skin Solutions For All.

28 employees
Health Care, Wellness Beauty

FAQ About Galderma

Advancing dermatology for every skin story
Galderma was founded in 1981.
Galderma is headquartered in Zug, Switzerland.
Galderma has a B2B2C, B2B and B2C business model. Its revenue comes from Product Sales and Service Fee.
Galderma has approximately 8994 employees.
Galderma has completed 9 funding rounds, raising a total of $22.95B. The latest funding stage is Post IPO.
Galderma offers: Injectable Aesthetic Solutions, Dermatological Skincare Products, Clinical Dermatology Solutions, Innovative Dermatology Research, Educational and Support Activities.
Top alternatives and competitors to Galderma include CENTER FOR DERMATOLOGY AND DERMATOLOGIC SURGERY THE, Arsenault Dermatology, Dermatology Associates of Rochester. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Galderma and CENTER FOR DERMATOLOGY AND DERMATOLOGIC SURGERY THE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Galderma, https://bouncewatch.com/company/galderma, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout